Science Angel Syndicate (SAS) are excited to announce their investment alongside Future Planet Capital and Bristol Private Equity Club (BPEC) into Zentraxa who are developing their innovative Zentide platform for engineering bespoke biomaterials.

MitoRx Therapeutics secures investment from Science Angel Syndicate to develop its first-in-class therapeutics that target dysfunctional sulfide-signalling in mitochondria to halt the progress of degenerative diseases.

WASE, a modular bioenergy production and wastewater treatment company based in London, UK, have secured a £1m Seed funding round to accelerate the commercialisation of their technology to help the food and drinks industry become net carbon neutral.